ADAR1 CAPITAL MANAGEMENT, LLC purchased 14.1% of their position (922.85K shares) of TENAX THERAPEUTICS, INC. on the open market
Open‑market purchase worth $1.46M — a moderate purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 10/21/2026ACC: 0001940272-26-000027
10% Owner
Since Aug 2026
+922.85K
Net shares
Net buyer
$1.46M
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
922.85K acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+336.53K
Price / share
$1.51
Trade value
$507.01K
% of position
5.2%
10/19/2026
6.52M→6.86M
Common Stock
Indirect
Shares
+254.34K
Price / share
$1.60
Trade value
$405.73K
% of position
3.7%
10/20/2026
6.86M→7.12M
Common Stock
Indirect
Shares
+331.98K
Price / share
$1.66
Trade value
$550.69K
% of position
4.7%
10/21/2026
7.12M→7.45M
Total
Net shares
+922.85K
Net value
$1.46M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/19/2026 | P · Purchase | +336.53K | $1.51 | $507.01K | 5.2% | 6.52M | 6.86M |
| Common Stock Indirect | 10/20/2026 | P · Purchase | +254.34K | $1.60 | $405.73K | 3.7% | 6.86M | 7.12M |
| Common Stock Indirect | 10/21/2026 | P · Purchase | +331.98K | $1.66 | $550.69K | 4.7% | 7.12M | 7.45M |
| Total | +922.85K | $1.46M | ||||||
Derivative Transactions0
No derivative transactions reported